Drug Farm and Amoytop Biotech Collaborate on DF-006 for HBV and HCC
CompanyDeals

Drug Farm and Amoytop Biotech Collaborate on DF-006 for HBV and HCC

Eisai's Dayvigo Granted NMPA Approval for Insomnia Treatment
CompanyDrug

Eisai’s Dayvigo Granted NMPA Approval for Insomnia Treatment

Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China
CompanyDeals

Harbin Gloria Partners with Kowa Pharmaceuticals to Promote Parmodia in China

BeiGene and Amgen Report Positive Results for Tarlatamab in Chinese ES-SCLC Patients
CompanyDrug

BeiGene and Amgen Report Positive Results for Tarlatamab in Chinese ES-SCLC Patients

Ayshealth Technology Secures Angel Funding for Artificial Blood Vessel Research
CompanyDeals

Ayshealth Technology Secures Angel Funding for Artificial Blood Vessel Research

Shanghai Pharma Collaborates with Novartis China on Ophthalmic Products
CompanyDeals

Shanghai Pharma Collaborates with Novartis China on Ophthalmic Products

Kexing Pharma's GB18 Receives NMPA Approval for Cancer Cachexia Trial
CompanyDrug

Kexing Pharma’s GB18 Receives NMPA Approval for Cancer Cachexia Trial

Gilead Sciences to Acquire Hookipa's HB-400 and HB-500 Vaccine Programs
CompanyDeals

Gilead Sciences to Acquire Hookipa’s HB-400 and HB-500 Vaccine Programs

Hengrui Pharmaceuticals Gains NMPA Approval for SHR-4712 Clinical Trial
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for SHR-4712 Clinical Trial

Bio-Thera Solutions Terminates BAT3306 Trial Amid Biosimilar Policy Shifts
CompanyDrug

Bio-Thera Solutions Terminates BAT3306 Trial Amid Biosimilar Policy Shifts

Fosun Pharma's HLX22 Granted Orphan Drug Designation by EU Commission
CompanyDrug

Fosun Pharma’s HLX22 Granted Orphan Drug Designation by EU Commission

UCB Launches Rystiggo in China for Generalized Myasthenia Gravis
CompanyDrug

UCB Launches Rystiggo in China for Generalized Myasthenia Gravis